Abstract:Previous work showed that 3‐month‐old remyelination deficient mice (Myrf ICKOs) regain locomotor function comparably to remyelination competent (Myrf‐Intact) controls after spinal cord injury. This study investigated the mechanisms by which mice compensate for remyelination failure after injury. Spared axons through the lesions of Myrf ICKOs conduct action potentials at comparable velocities to controls. The Myrf ICKOs exhibit subtle differences in gait cycle, without deficits, implying compensatory mechanisms cause subtle locomotor effects. A novel ion channel expression pattern of long sections of Nav1.2 colocalized with Kv1.2 channels was only observed in the Myrf ICKO. These data demonstrate potential compensatory mechanisms for demyelination and may have implications for future therapeutic interventions for spinal cord injury. The development of therapeutic strategies to reduce impairments following spinal cord injury (SCI) motivates an active area of research, because there are no effective therapies. One strategy is to address injury‐induced demyelination of spared axons by promoting endogenous or exogenous remyelination. However, previously, we showed that new myelin was not necessary to regain hindlimb stepping following moderate thoracic spinal cord contusion in 3‐month‐old mice. The present analysis investigated two potential mechanisms by which animals can re‐establish locomotion in the absence of remyelination: compensation through intact white matter and conduction through spared axons. We induced a severe contusion injury to reduce the spared white matter rim in the remyelination deficient model, with no differences in recovery between remyelination deficient animals and injured littermate controls. We investigated the nodal properties of the axons at the lesion and found that in the remyelination deficient model, axons express the Nav1.2 voltage‐gated sodium channel, a sub‐type not typically expressed at mature nodes of Ranvier. In a moderate contusion injury, conduction velocities through the lesions of remyelination deficient animals were similar to those in animals with the capacity to remyelinate after injury. Detailed gait analysis and kinematics reveal subtle differences between remyelination deficient animals and remyelination competent controls, but no worse deficits. It is possible that upregulation of Nav1.2 channels may contribute to establishing conduction through the lesion. This conduction could contribute to compensation and regained motor function in mouse models of SCI. Such compensatory mechanism may have implications for interpreting efficacy results for remyelinating interventions in mice and the development of therapies for improving recovery following SCI.

NKCC1 inhibition reduces periaxonal swelling, increases white matter sparing, and improves neurological recovery after contusive SCI

Reduction of prolonged excitatory neuron swelling after spinal cord injury improves locomotor recovery in mice

MCC950 Reduces Neuronal Apoptosis in Spinal Cord Injury in Mice

Targeting connexin 43 expression via scaffold mediated delivery of antisense oligodeoxynucleotide preserves neurons, enhances axonal extension, reduces astrocyte and microglial activation after spinal cord injury

Pretreatment with AQP4 and NKCC1 Inhibitors Concurrently Attenuated Spinal Cord Edema and Tissue Damage after Spinal Cord Injury in Rats.

P2Y12 Receptor Mediates Apoptosis and Demyelination to Affect Functional Recovery in Mice with Spinal Cord Injury.

Improving Functional Recovery after Severe Spinal Cord Injury by a Noninvasive Dual Functional Approach of Neuroprotection and Neuromodulation

Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury

Inhibiting the NF-κB/DRP1 Axis Affords Neuroprotection after Spinal Cord Injury via Inhibiting Polarization of Pro-Inflammatory Microglia

Combined biomaterial scaffold and neuromodulation strategy to promote tissue repair and corticospinal connectivity after spinal cord injury in a rodent model

NKCC1 Inhibition Attenuates Chronic Cerebral Hypoperfusion-Induced White Matter Lesions by Enhancing Progenitor Cells of Oligodendrocyte Proliferation

Non-resolving neuroinflammation regulates axon regeneration in chronic spinal cord injury

Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury

Inhibition of astrocyte hemichannel improves recovery from spinal cord injury

A N-Cadherin Nano-Antagonist Hydrogel Enhances Recovery from Spinal Cord Injury by Impeding Glial Scarring

Compensatory changes after spinal cord injury in a remyelination deficient mouse model

Combined effect of trifluoperazine and sodium cromoglycate on reducing acute edema and limiting lasting functional impairments after spinal cord injury in rats

Cystine–glutamate antiporter deletion accelerates motor recovery and improves histological outcomes following spinal cord injury in mice

Effects of CFTR-ENaC on spinal cord edema after spinal cord injury

Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury

Attenuating Neurogenic Sympathetic Hyperreflexia Robustly Improves Antibacterial Immunity After Chronic Spinal Cord Injury